TY - JOUR
T1 - BRCA1/2 mutations perturb telomere biology
T2 - Characterization of structural and functional abnormalities in vitro and in vivo
AU - Uziel, Orit
AU - Yerushalmi, Rinat
AU - Zuriano, Lital
AU - Naser, Shaden
AU - Beery, Einat
AU - Nordenberg, Jardena
AU - Lubin, Ido
AU - Adel, Yonatan
AU - Shepshelovich, Daniel
AU - Yavin, Hagai
AU - Aharon, Irit Ben
AU - Pery, Shlomit
AU - Rizel, Shulamit
AU - Pasmanik-Chor, Metsada
AU - Frumkin, Dan
AU - Lahav, Meir
PY - 2016
Y1 - 2016
N2 - BRCA1 mutation is associated with carcinogenesis, especially of breast tissue. Telomere maintenance is crucial for malignant transformation. Being a part of the DNA repair machinery, BRCA1 may be implicated in telomere biology. We explored the role of BRCA1 in telomere maintenance in lymphocytes of BRCA1/2 mutation carriers and in in vitro system by knocking down its expression in non-malignant breast epithelial cells. The results in both systems were similar. BRCA1/2 mutation caused perturbation of telomere homeostasis, shortening of the single stranded telomere overhang and increased the intercellular telomere length variability as well as the number of telomere free chromosomal ends and telomeric circles. These changes resulted in an increased DNA damage status. Telomerase activity, inducibility and expression remained unchanged. BRCA1 mutation resulted also in changes in the binding of shelterin proteins to telomeres. DNMT-1 levels were markedly reduced both in the carriers and in in vitro system. The methylation pattern of the sub-telomeric regions in carriers suggested hypomethylation in chromosome 10. The expression of a distinct set of genes was also changed, some of which may relate to pre-disposition to malignancy. These results show that BRCA gene products have a role in telomere length homeostasis. It is plausible that these perturbations contribute to malignant transformation in BRCA mutants.
AB - BRCA1 mutation is associated with carcinogenesis, especially of breast tissue. Telomere maintenance is crucial for malignant transformation. Being a part of the DNA repair machinery, BRCA1 may be implicated in telomere biology. We explored the role of BRCA1 in telomere maintenance in lymphocytes of BRCA1/2 mutation carriers and in in vitro system by knocking down its expression in non-malignant breast epithelial cells. The results in both systems were similar. BRCA1/2 mutation caused perturbation of telomere homeostasis, shortening of the single stranded telomere overhang and increased the intercellular telomere length variability as well as the number of telomere free chromosomal ends and telomeric circles. These changes resulted in an increased DNA damage status. Telomerase activity, inducibility and expression remained unchanged. BRCA1 mutation resulted also in changes in the binding of shelterin proteins to telomeres. DNMT-1 levels were markedly reduced both in the carriers and in in vitro system. The methylation pattern of the sub-telomeric regions in carriers suggested hypomethylation in chromosome 10. The expression of a distinct set of genes was also changed, some of which may relate to pre-disposition to malignancy. These results show that BRCA gene products have a role in telomere length homeostasis. It is plausible that these perturbations contribute to malignant transformation in BRCA mutants.
KW - BRCA1/2
KW - Malignant transformation
KW - Telomere homeostasis
KW - Telomeres
UR - http://www.scopus.com/inward/record.url?scp=84962240996&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.5693
DO - 10.18632/oncotarget.5693
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84962240996
SN - 1949-2553
VL - 7
SP - 2433
EP - 2454
JO - Oncotarget
JF - Oncotarget
IS - 3
ER -